FDA Notice: Prescription Drugs Recalled After Dangerous Label Mix-Up

A pharmaceutical company issued a nationwide recall of a medication due to mislabeled packaging, the FDA says.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A pharmaceutical company issued a nationwide recall of a medication due to mislabeled packaging, according to a notice published by the U.S. Food and Drug Administration (FDA).

Massachusetts-based Azurity Pharmaceuticals recalled one lot of Zenzedi CII dextroamphetamine sulfate tablets last week, which was shipped between Aug. 23 and Nov. 29, 2023. The drug can be used to treat narcolepsy and attention-deficit-hyperactivity disorder (ADHD), although it is sometimes abused and can be addictive, according to federal health officials.